Improving tumor/muscle and tumor/blood ratios of 99mTc-labeled nitroimidazole propylene amine oxime (PnAO) complexes with ethylene glycol linkers.

Improving tumor/muscle and tumor/blood ratios of 99mTc-labeled nitroimidazole propylene amine oxime (PnAO) complexes with ethylene glycol linkers.
复制标题

DOI:
10.1016/j.bmcl.2023.129154
复制
发表时间:
2023-01
影响因子:
2.7
通讯作者:
Shuo Li;Taiwei Chu
Shuo Li;Taiwei Chu
中科院分区:
医学4区
文献类型:
--
作者:
Shuo Li;Taiwei Chu

文献摘要

相似文献

合成了3种不同乙二醇链长的硝基咪唑丙烯胺肟(PnAO)衍生物,并用99 mTc进行标记。~(99)mTc标记的氧代[[6,6,12,12-四甲基-1,17-双]配合物的放射化学纯度(2-硝基-1H-咪唑-1-基)-3,15-二氧杂-7,11-二氮杂十七烷-5,13-二酮二肟基](3-)-N,N′,N′′,N′′]-锝-99 m(99 mTc-2 P2 O 1),氧代[[9,9,15,15-四甲基-1,23-双(2-硝基-1H-咪唑-1-基)-3,6,18,21-四氧杂-10,14-二氮杂二十三烷-8,16-二酮二肟基](3-)-N,N′,N ′′,N′]-锝-99 m(99 mTc-2 P2 O2)和氧代[[15,15,21,21-四甲基-1,35-双(2-硝基-1H-咪唑-1-基)-3,6,9,12,24,27,30,33-八氧杂-16,20-二氮杂三十五烷-14,22-二酮二肟基](3-)-N,N′,N′′,N′′]-锝-99 m(99mTc-2P_2O_4)、(99mTc-2P_2所有配合物均表现出良好的缺氧选择性。在S180荷瘤小鼠中的生物分布研究的结果表明,肿瘤/肌肉(T/M)比(7.20 ± 2.37,7.19 ± 1.75,5.56 ± 1.10)和肿瘤/血液(T/B)比值(1.66 ± 0.34,1.73 ± 0.25,2.13 ± 0.19)显著高于无乙二醇链的99 mTc-2 P2(3.24 ± 0.65,0.81 ± 0.34)。其中99 mTc-2 P2 O 4的T/B比最好。通过加入合适长度的乙二醇链,新的配合物具有更高的肿瘤/血液和肿瘤/肌肉比。为乏氧显像剂的设计和优化提供了理论依据。
Three nitroimidazole propylene amine oxime (PnAO) derivatives with different lengths of ethylene glycol chain were synthesized and radiolabeled with99mTc. The radiochemical purities of three99mTc-labeled complexes, oxo[[6,6,12,12-tetramethyl-1,17-bis(2-nitro-1H-imidazol-1-yl)-3,15-dioxa-7,11-diazaheptadecane-5, 13-dione dioximato] (3-)-N,N′,N′′,N′′′]-technetium-99m (99mTc-2P2O1), oxo[[9,9,15,15-tetramethyl-1,23-bis(2-nitro-1H-imidazol-1-yl)-3,6,18,21-tetraoxa-10, 14-diazatricosane-8,16-dione dioximato] (3-)-N,N′,N′′,N′′′]-technetium-99m (99mTc-2P2O2) and oxo[[15,15,21,21-tetramethyl-1,35-bis(2-nitro-1H-imidazol-1-yl)-3,6,9,12,24,27,30,33-octaoxa-16,20-diazapentatriacontane-14,22-dione dioximato] (3-)-N,N′,N′′,N′′′]-technetium-99m (99mTc-2P2O4), were above 90%, and they were all stable bothin vitroandin vivo.The hypoxia/normoxia uptake ratios of the three complexes were 2.92 ± 0.61, 2.63 ± 0.64 and 2.29 ± 0.67 in S180 cellular uptake assay (4 h). All of these complexes presented good hypoxia selectivity. The results of biodistribution studies in S180 tumor-bearing mice revealed that the tumor/muscle (T/M) ratios (7.20 ± 2.37, 7.19 ± 1.75, 5.56 ± 1.10) and tumor/blood (T/B) ratios (1.66 ± 0.34, 1.73 ± 0.25, 2.13 ± 0.19) at 4 h of three complexes were significantly higher than those of99mTc-2P2 (3.24 ± 0.65, 0.81 ± 0.34) without the ethylene glycol chains. Among them,99mTc-2P2O4 had the best T/B ratio. The new complexes have higher tumor/blood and tumor/muscle ratios by adding suitable length of ethylene glycol chain. It is helpful for the design and optimization of hypoxic imaging agents.